158 related articles for article (PubMed ID: 36060366)
1. Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits.
Hara JH; Gutiontov SI; Uddin S; Rosenberg AJ; Pearson AT; Gooi Z; Blair EA; Agrawal N; Vokes EE; Ginat DT; Haraf DJ; Juloori A
Cureus; 2022 Jul; 14(7):e27521. PubMed ID: 36060366
[TBL] [Abstract][Full Text] [Related]
2. Low contralateral neck recurrence risk with ipsilateral neck radiotherapy in N2b tonsillar squamous cell carcinoma.
Natesan D; Cramer CK; Oyekunle T; Niedzwiecki D; Brizel DM; Mowery YM
Oral Oncol; 2023 Apr; 139():106362. PubMed ID: 36931141
[TBL] [Abstract][Full Text] [Related]
3. Association of Unilateral Radiotherapy With Contralateral Lymph Node Failure Among Patients With Squamous Cell Carcinoma of the Tonsil: A Systematic Review and Meta-analysis.
Razavian NB; D'Agostino RB; Steber CR; Helis CA; Hughes RT
JAMA Netw Open; 2023 Feb; 6(2):e2255209. PubMed ID: 36753275
[TBL] [Abstract][Full Text] [Related]
4. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
5. Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer - Approach with caution.
Maskell D; Buckley H; Sission K; Roques T; Geropantas K
Head Neck; 2019 Sep; 41(9):2937-2946. PubMed ID: 31059180
[TBL] [Abstract][Full Text] [Related]
6. Omitting Elective Irradiation of the Contralateral Retropharyngeal Nodes in Oropharyngeal Squamous Cell Carcinoma Treated with Intensity-modulated Radiotherapy.
Nagatsuka M; Hughes RT; Shenker RF; Frizzell BA; Greven KM
Cureus; 2019 Jan; 11(1):e3825. PubMed ID: 30868038
[TBL] [Abstract][Full Text] [Related]
7. Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial.
de Veij Mestdagh PD; Schreuder WH; Vogel WV; Donswijk ML; van Werkhoven E; van der Wal JE; Dirven R; Karakullukcu B; Sonke JJ; van den Brekel MWM; Marijnen CAM; Al-Mamgani A
BMC Cancer; 2019 Nov; 19(1):1110. PubMed ID: 31727019
[TBL] [Abstract][Full Text] [Related]
8. Low risk of contralateral lymph node recurrence in lateralized head and neck carcinoma after postoperative ipsilateral radiotherapy.
Wirtz MM; Temming S; Kocher M; Kunze S; Semrau R
Strahlenther Onkol; 2020 May; 196(5):474-484. PubMed ID: 31832696
[TBL] [Abstract][Full Text] [Related]
9. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach.
Rusthoven KE; Raben D; Schneider C; Witt R; Sammons S; Raben A
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1365-70. PubMed ID: 19168295
[TBL] [Abstract][Full Text] [Related]
10. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
[TBL] [Abstract][Full Text] [Related]
11. Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer.
Sher DJ; Pham NL; Shah JL; Sen N; Williams KA; Subramaniam RM; Moore W; Chorley R; Ahn C; Khan SM
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):932-940. PubMed ID: 33127491
[TBL] [Abstract][Full Text] [Related]
12. SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma.
de Veij Mestdagh PD; Jonker MCJ; Vogel WV; Schreuder WH; Donswijk ML; Klop WMC; Al-Mamgani A
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2135-2144. PubMed ID: 29955968
[TBL] [Abstract][Full Text] [Related]
13. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach.
Dan TD; Raben D; Schneider CJ; Hockstein NG; Witt RL; Dzeda M; Cormier JF; Raben A
Oral Oncol; 2015 Jun; 51(6):616-21. PubMed ID: 25868716
[TBL] [Abstract][Full Text] [Related]
14. Cancer of the tonsil: the results of ipsilateral radiation treatment.
Jackson SM; Hay JH; Flores AD; Weir L; Wong FL; Schwindt C; Baerg B
Radiother Oncol; 1999 May; 51(2):123-8. PubMed ID: 10435802
[TBL] [Abstract][Full Text] [Related]
15. Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes.
Lin P; Min M; Lai K; Lee M; Holloway L; Xuan W; Bray V; Fowler A; Lee CS; Yong J
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e586-e598. PubMed ID: 34373179
[TBL] [Abstract][Full Text] [Related]
16. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
17. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
[TBL] [Abstract][Full Text] [Related]
18. Incidence of contralateral-bilateral nodes in the human papillomavirus era.
Tritter AG; Mehta V; Samuelson M; deGravelle G; Ma X; Medlin-Moore T; Takalkar A; Caldito G; Nathan CO
Laryngoscope; 2017 Jun; 127(6):1328-1333. PubMed ID: 27905120
[TBL] [Abstract][Full Text] [Related]
19. Risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery followed by adjuvant radiotherapy for human papilloma virus-associated tonsil cancer.
Gershowitz J; Chao HH; Doucette A; Lukens JN; Swisher-McClure S; Weinstein GS; O'Malley BW; Chalian AA; Rassekh CH; Newman JG; Cohen RB; Bauml JM; Aggarwal C; Lin A
Br J Radiol; 2019 Dec; 92(1104):20190466. PubMed ID: 31600090
[TBL] [Abstract][Full Text] [Related]
20. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
